ADIPOQ and Obesity: These results may be explained by new data showing that elevated FGF21 levels in individuals with obesity serve as a defense mechanism to protect against systemic IR through upregulation of adiponectin in subcutaneous but not visceral fat, followed by anti-inflammatory action resulting from local M2 macrophage polarization [37].